000 | 01777 a2200505 4500 | ||
---|---|---|---|
005 | 20250513092715.0 | ||
264 | 0 | _c19960823 | |
008 | 199608s 0 0 eng d | ||
022 | _a0022-2623 | ||
024 | 7 |
_a10.1021/jm950711l _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJefferies, P R | |
245 | 0 | 0 |
_aRyanodine action at calcium release channels. 1. importance of hydroxyl substituents. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cJun 1996 |
||
300 |
_a2331-8 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBoron Compounds _xmetabolism |
650 | 0 | 4 | _aBrain Chemistry |
650 | 0 | 4 |
_aCalcium _xmetabolism |
650 | 0 | 4 |
_aCalcium Channels _xdrug effects |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 |
_aEpoxy Compounds _xmetabolism |
650 | 0 | 4 |
_aHydroxides _xchemistry |
650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
650 | 0 | 4 | _aMethylation |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 |
_aMuscle Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
650 | 0 | 4 |
_aNerve Tissue Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aOxygen _xmetabolism |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aRyanodine _xpharmacology |
650 | 0 | 4 | _aRyanodine Receptor Calcium Release Channel |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aBlumenkopf, T A | |
700 | 1 | _aGengo, P J | |
700 | 1 | _aCole, L C | |
700 | 1 | _aCasida, J E | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 39 _gno. 12 _gp. 2331-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm950711l _zAvailable from publisher's website |
999 |
_c8688760 _d8688760 |